• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Michael Quilty, CEO, Matrix Medical Network

Article

A founding member of the board of directors of DMAA, Michael Quilty created Matrix Medical Network in 2001 to manage the sickest Medicare Advantage and Special Needs plan members.

Michael Quilty
CEO
Matrix Medical Network

By itself, the higher but more appropriate risk-based reimbursement for these members earned through these assessments would provide a very positive return on investment to Medicare Advantage plans. But it is the combination of these higher revenues along with substantially reduced hospitalizations (30% to 50% reduction in acute care readmissions for SNF patients, for example) that credits Matrix as the highest-return vendor in the industry, according to DMPC.

Previously, Quilty was vice president of business development for Integrated Healthcare Networks and director of business development at Pfizer Health Solutions.

Related Content
© 2024 MJH Life Sciences

All rights reserved.